WO2019062027A1 - Green preparation method for n-substituted-l-pyroglutamic acid ester - Google Patents
Green preparation method for n-substituted-l-pyroglutamic acid ester Download PDFInfo
- Publication number
- WO2019062027A1 WO2019062027A1 PCT/CN2018/078071 CN2018078071W WO2019062027A1 WO 2019062027 A1 WO2019062027 A1 WO 2019062027A1 CN 2018078071 W CN2018078071 W CN 2018078071W WO 2019062027 A1 WO2019062027 A1 WO 2019062027A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- substituted
- glutamic acid
- alcohol
- acid ester
- reaction temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Definitions
- the invention relates to a green preparation method of N-substituted-L-pyroglutamic acid ester, belonging to the field of pharmaceutical biochemical industry.
- N-substituted-L-pyroglutamic acid ester (I) is an important chemical and pharmaceutical intermediate.
- N-substituted-L-pyroglutamic acid ester can be used to prepare novel extended-spectrum ⁇ -
- the amidase inhibitor ababatan, patents CN103649051A, CN105294690A, US20140275001 all use a N-substituted-L-pyroglutamic acid ester (I) to prepare ababatam.
- the structural formula of N-substituted-L-pyroglutamic acid ester (I) and avivatan is as follows:
- the existing N-substituted-L-pyroglutamic acid ester (I) is prepared by reacting pyroglutamic acid with benzyl chloride, an organic base, 1,2-dichloroethane (CN105732454A method) or bromine.
- benzyl, organic base and acetone are reacted (CN105130870A method) to obtain L-pyroglutamic acid ester, which is further protected to obtain N-substituted-L-pyroglutamic acid ester. See Reaction Route 1.
- the above methods all use stimulating bromobenzyl or benzyl chloride as raw materials, long reaction time, low production efficiency, large amount of waste water; additionally, the price of pyroglutamic acid is higher, and pyroglutamic acid needs high temperature from glutamic acid (150 -160 ° C) melt preparation, inconvenient operation, post-processing is cumbersome, requires multiple decolorization, decolorization process produces a large amount of wastewater, the yield is only 75%; and the above process requires three operation steps in the preparation process, the process route is long, which is not conducive to green production .
- the present invention provides a green preparation method of N-substituted-L-pyroglutamic acid ester (I).
- the raw material of the invention is cheap and easy to obtain, the reaction type is classic, the process route is short, and the operation is simple.
- the amount of waste water is small, the production process is green and environmentally friendly, the reaction yield is high, and the product cost is low.
- a method for preparing N-substituted-L-pyroglutamic acid ester comprising the steps of:
- L-glutamic acid (II) as a starting material, in the presence of an alcohol and an acidic reagent, esterification reaction to prepare L-glutamic acid diester hydrochloride (III);
- R in the formula III is a C 1-6 saturated aliphatic group or an alkyl-substituted phenyl group.
- the L-glutamic acid diester hydrochloride (III) obtained in the step (1) is subjected to an N-substituted protection reaction with an N-substituent protecting agent in the presence of a base and a solvent to introduce an N-substituted protecting group, By dealcoholation ring to obtain N-substituted-L-pyroglutamic acid ester (I);
- R in the formula I is the same as R in the formula III, and PG is in a tert-butyloxycarbonyl group, a benzyloxycarbonyl group, an ethyloxycarbonyl group, an allyloxycarbonyl group or a phenyloxycarbonyl group.
- PG is in a tert-butyloxycarbonyl group, a benzyloxycarbonyl group, an ethyloxycarbonyl group, an allyloxycarbonyl group or a phenyloxycarbonyl group.
- the alcohol of the step (1) is one of a C 1-6 saturated fatty alcohol, an aromatic alcohol or an alkyl-substituted aromatic alcohol.
- the alcohol is methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol, tert-butanol, n-pentanol, isoamyl alcohol, tert-amyl alcohol, hexanol, benzyl alcohol, ortho One of methylbenzyl alcohol or p-methylbenzyl alcohol; further preferably, the alcohol is one of benzyl alcohol, ethanol, tert-butanol or methanol.
- the mass ratio of the alcohol to L-glutamic acid (II) in step (1) is from 8 to 30:1.
- the acidic reagent in the step (1) is one of thionyl chloride, triphosgene or diphosgene.
- the molar ratio of the thionyl chloride to L-glutamic acid (II) is 2.0-10.0:1; the esterification reaction temperature is 40-85 ° C; further preferably, the esterification reaction temperature It is 60-85 ° C.
- the reaction time is 1-8 hours.
- the molar ratio of the triphosgene to L-glutamic acid (II) is 0.33-2.5:1; the esterification reaction temperature is 50-100 ° C; further preferably, the esterification reaction temperature is 60 -80 ° C.
- the reaction time is 1-8 hours.
- the molar ratio of the diphosgene to the L-glutamic acid (II) is from 0.5 to 3.5:1; the esterification reaction temperature is from 50 to 100 ° C; further preferably, the esterification reaction temperature is 60-80 ° C.
- the reaction time is 1-8 hours.
- the molar ratio of the acidic reagent to L-glutamic acid (II) in step (1) is from 0.33 to 10.0:1.
- the esterification reaction temperature in the step (1) is from 30 to 100 ° C; preferably, the esterification reaction temperature is from 40 to 85 ° C.
- the esterification reaction time in step (1) is from 1 to 8 hours.
- the base in the step (2) is an inorganic base or an organic base;
- the inorganic base is potassium carbonate, sodium carbonate, calcium carbonate, potassium hydrogencarbonate, sodium hydrogencarbonate, calcium hydrogencarbonate, potassium acetate, One or a combination of two or more of sodium acetate, calcium acetate, sodium hydride, sodium methoxide, sodium ethoxide, sodium t-butoxide, potassium t-butoxide or sodium benzylate;
- the organic base is triethylamine, three-positive One or a combination of two or more of butylamine, diisopropylethylamine or pyridine.
- the molar ratio of the base to the L-glutamic acid diester hydrochloride (III) in step (2) is from 1.0 to 2.0:1.
- the solvent in the step (2) is 1,2-dichloroethane, 1,1,2-trichloroethane, tetrahydrofuran, 2-methyltetrahydrofuran, methoxycyclopentane, One or a combination of two or more of benzene, toluene or xylene.
- the mass ratio of the solvent to the L-glutamic acid diester hydrochloride (III) in the step (2) is from 4 to 20:1.
- the N-substituent protecting agent in the step (2) is di-tert-butyl dicarbonate, benzyl chloroformate, ethyl chloroformate, allyl chloroformate, tert-butyl chloroformate. Or one of phenyl chloroformate.
- the molar ratio of the N-substituent protecting agent to the L-glutamic acid diester hydrochloride (III) in the step (2) is from 1.0 to 2.0:1.
- the N-substituted protection reaction temperature in the step (2) is from -20 to 80 ° C; preferably, the N-substituted protection reaction temperature is from 20 to 50 ° C.
- the N-substituent protection reaction time in step (2) is from 2 to 10 hours.
- the dealcoholization ring-closing reaction temperature in the step (2) is from 60 to 120 ° C; preferably, the dealcoholization ring-closing reaction temperature is from 70 to 105 ° C.
- the dealcoholation ring closure reaction time of step (2) is from 2 to 8 hours.
- the present invention uses L-glutamic acid (II) as a starting material to prepare L-glutamic acid diester hydrochloride (III) by esterification in the presence of an alcohol and an acidic reagent;
- the N-substituent protecting reagent is introduced into the N-substituted protecting group, and the in-molecular dealcoholation is carried out by heating, and the "one-pot method” is carried out to obtain N-substituted-L-pyroglutamic acid ester (I).
- the invention does not use bromine or benzyl chloride, and is harmless and environmentally friendly; the invention uses L-glutamic acid (II) as a starting material, and the raw materials are cheap and easy to obtain, and the reaction type is classic.
- the invention has the advantages of short process route, simple operation and low product cost; the invention does not need to wash the product, the amount of waste water is small, and the organic raw materials such as the solvent used can be recycled and reused, environmentally friendly, can effectively reduce the cost; and the reaction yield is high, The total yield is as high as 93.4%.
- reaction process and product purity were monitored by gas phase or liquid chromatography, and the optical purity (area ratio %) was measured by a liquid chromatograph equipped with a chiral column (ES-OVS, 150 mm ⁇ 4.6 mm, Agilent), and the calculation was performed. Rate and ee% value.
- the nuclear magnetic data of the obtained product are as follows: 1 H-NMR (400 MHz, CDCl 3 ) ⁇ : 1.42 (9H, s), 2.01 (1H, m), 2.30 (1H, m), 2.49 (1H, m), 2.58 (1H, m), 4.63 (1H, t), 5.20 (2H, m), 7.36 (5H, m).
- the nuclear magnetic data of the obtained product are as follows: 1 H-NMR (400 MHz, CDCl 3 ) ⁇ : 1.21 (3H, t), 1.46 (9H, s), 2.02 (1H, m), 2.31 (1H, m), 2.48 (1H, m), 2.59 (1H, m), 4.16 (2H, q), 4.61 (1H, m).
- the nuclear magnetic data of the obtained product are as follows: 1 H-NMR (400 MHz, CDCl 3 ) ⁇ : 2.06 (1H, m), 2.34 (m, 1H), 2.50 (m, 1H), 2.61 (1H, m), 4.72 (1H, m), 5.12 (2H, s), 5.21 (s, 2H), 7.40-7.20 (m, 10H).
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
本发明涉及一种N-取代-L-焦谷氨酸酯的绿色制备方法,属于医药生物化工领域。The invention relates to a green preparation method of N-substituted-L-pyroglutamic acid ester, belonging to the field of pharmaceutical biochemical industry.
N-取代-L-焦谷氨酸酯(I)是一种重要的化工、医药中间体,在医药领域,N-取代-L-焦谷氨酸酯可用于制备新型超广谱β-内酰胺酶抑制剂阿维巴坦,专利CN103649051A、CN105294690A、US20140275001均使用N-取代-L-焦谷氨酸酯(I)制备阿维巴坦。N-取代-L-焦谷氨酸酯(I)和阿维巴坦的结构式如下:N-substituted-L-pyroglutamic acid ester (I) is an important chemical and pharmaceutical intermediate. In the field of medicine, N-substituted-L-pyroglutamic acid ester can be used to prepare novel extended-spectrum β- The amidase inhibitor ababatan, patents CN103649051A, CN105294690A, US20140275001 all use a N-substituted-L-pyroglutamic acid ester (I) to prepare ababatam. The structural formula of N-substituted-L-pyroglutamic acid ester (I) and avivatan is as follows:
现有N-取代-L-焦谷氨酸酯(I)制备方法是以焦谷氨酸为原料,和氯苄、有机碱、1,2-二氯乙烷反应(CN105732454A方法)或和溴苄、有机碱、丙酮反应(CN105130870A方法)得到L-焦谷氨酸酯,再进行保护得到N-取代-L-焦谷氨酸酯。见反应路线1。The existing N-substituted-L-pyroglutamic acid ester (I) is prepared by reacting pyroglutamic acid with benzyl chloride, an organic base, 1,2-dichloroethane (CN105732454A method) or bromine. The benzyl, organic base and acetone are reacted (CN105130870A method) to obtain L-pyroglutamic acid ester, which is further protected to obtain N-substituted-L-pyroglutamic acid ester. See Reaction Route 1.
以上方法均使用刺激性强的溴苄或氯苄为原料,反应时间长,生产效率低,废水量大;另外焦谷氨酸价格较高,而焦谷氨酸需要由谷氨酸高温(150-160℃)熔融制备,操作不便,后处理繁琐,需要多次脱色,脱色过程产生大量废水,收率只有75%;且上述方法制备过程需要三个操作步骤,工艺路线长,不利于绿色生产。The above methods all use stimulating bromobenzyl or benzyl chloride as raw materials, long reaction time, low production efficiency, large amount of waste water; additionally, the price of pyroglutamic acid is higher, and pyroglutamic acid needs high temperature from glutamic acid (150 -160 ° C) melt preparation, inconvenient operation, post-processing is cumbersome, requires multiple decolorization, decolorization process produces a large amount of wastewater, the yield is only 75%; and the above process requires three operation steps in the preparation process, the process route is long, which is not conducive to green production .
发明内容Summary of the invention
针对现有技术的不足,本发明提供一种N-取代-L-焦谷氨酸酯(I)的绿色制备方法,本发明原料价廉易得,反应类型经典,工艺路线短,操作简便,废水量少,生产过程绿色环保,反应收率高,产品成本低。In view of the deficiencies of the prior art, the present invention provides a green preparation method of N-substituted-L-pyroglutamic acid ester (I). The raw material of the invention is cheap and easy to obtain, the reaction type is classic, the process route is short, and the operation is simple. The amount of waste water is small, the production process is green and environmentally friendly, the reaction yield is high, and the product cost is low.
本说明书中的化合物编号与结构式编号完全一致,具有相同的指代关系。The compound numbers in this specification are identical to the structural formula numbers and have the same reference relationship.
本发明的技术方案如下:The technical solution of the present invention is as follows:
一种N-取代-L-焦谷氨酸酯的制备方法,包括步骤:A method for preparing N-substituted-L-pyroglutamic acid ester, comprising the steps of:
(1)以L-谷氨酸(Ⅱ)为初始原料,在醇和酸性试剂存在下,经酯化反应制备L-谷氨酸二酯盐酸盐(III);(1) using L-glutamic acid (II) as a starting material, in the presence of an alcohol and an acidic reagent, esterification reaction to prepare L-glutamic acid diester hydrochloride (III);
其中,式III中的R为C 1-6的饱和脂肪基或烷基取代苯基。 Wherein R in the formula III is a C 1-6 saturated aliphatic group or an alkyl-substituted phenyl group.
(2)步骤(1)得到的L-谷氨酸二酯盐酸盐(III)在碱和溶剂的存在下,与N-取代基保护试剂发生N-取代保护反应引入N-取代保护基,经脱醇环合得N-取代-L-焦谷氨酸酯(I);(2) The L-glutamic acid diester hydrochloride (III) obtained in the step (1) is subjected to an N-substituted protection reaction with an N-substituent protecting agent in the presence of a base and a solvent to introduce an N-substituted protecting group, By dealcoholation ring to obtain N-substituted-L-pyroglutamic acid ester (I);
其中,式I中的R与式III中的R相同,PG为叔丁基氧基羰基、苄基氧基羰基、乙基氧基羰基、烯丙基氧基羰基或苯基氧基羰基中的一种。Wherein R in the formula I is the same as R in the formula III, and PG is in a tert-butyloxycarbonyl group, a benzyloxycarbonyl group, an ethyloxycarbonyl group, an allyloxycarbonyl group or a phenyloxycarbonyl group. One.
根据本发明优选的,步骤(1)所述醇为C 1-6的饱和脂肪醇、芳醇或烷基取代芳醇中的一种。 According to a preferred embodiment of the present invention, the alcohol of the step (1) is one of a C 1-6 saturated fatty alcohol, an aromatic alcohol or an alkyl-substituted aromatic alcohol.
优选的,所述醇为甲醇、乙醇、正丙醇、异丙醇、正丁醇、异丁醇、叔丁醇、正戊醇、异戊醇、叔戊醇、己醇、苄醇、邻甲基苄醇或对甲基苄醇中的一种;进一步优选的,所述醇为苄醇、乙醇、叔丁醇或甲醇中的一种。Preferably, the alcohol is methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol, tert-butanol, n-pentanol, isoamyl alcohol, tert-amyl alcohol, hexanol, benzyl alcohol, ortho One of methylbenzyl alcohol or p-methylbenzyl alcohol; further preferably, the alcohol is one of benzyl alcohol, ethanol, tert-butanol or methanol.
根据本发明优选的,步骤(1)中所述醇与L-谷氨酸(Ⅱ)的质量比为8-30:1。According to a preferred embodiment of the invention, the mass ratio of the alcohol to L-glutamic acid (II) in step (1) is from 8 to 30:1.
根据本发明优选的,步骤(1)中所述酸性试剂为氯化亚砜、三光气或双光气中的一种。According to a preferred embodiment of the present invention, the acidic reagent in the step (1) is one of thionyl chloride, triphosgene or diphosgene.
优选的,所述氯化亚砜和L-谷氨酸(Ⅱ)的摩尔比为2.0-10.0:1;所述酯化反应温度为40-85℃;进一步优选的,所述酯化反应温度为60-85℃。反应时间为1-8小时。Preferably, the molar ratio of the thionyl chloride to L-glutamic acid (II) is 2.0-10.0:1; the esterification reaction temperature is 40-85 ° C; further preferably, the esterification reaction temperature It is 60-85 ° C. The reaction time is 1-8 hours.
优选的,所述三光气和L-谷氨酸(Ⅱ)的摩尔比为0.33-2.5:1;所述酯化反应温度为50-100℃;进一步优选的,所述酯化反应温度为60-80℃。反应时间为1-8小时。Preferably, the molar ratio of the triphosgene to L-glutamic acid (II) is 0.33-2.5:1; the esterification reaction temperature is 50-100 ° C; further preferably, the esterification reaction temperature is 60 -80 ° C. The reaction time is 1-8 hours.
优选的,所述双光气和L-谷氨酸(Ⅱ)的摩尔比为0.5-3.5:1;所述酯化反应温度为50-100℃;进一步优选的,所述酯化反应温度为60-80℃。反应时间为1-8小时。Preferably, the molar ratio of the diphosgene to the L-glutamic acid (II) is from 0.5 to 3.5:1; the esterification reaction temperature is from 50 to 100 ° C; further preferably, the esterification reaction temperature is 60-80 ° C. The reaction time is 1-8 hours.
根据本发明优选的,步骤(1)中所述酸性试剂与L-谷氨酸(Ⅱ)的摩尔比为0.33-10.0:1。According to a preferred embodiment of the invention, the molar ratio of the acidic reagent to L-glutamic acid (II) in step (1) is from 0.33 to 10.0:1.
根据本发明优选的,步骤(1)中所述酯化反应温度为30-100℃;优选的,所述酯化反应温度为40-85℃。According to the preferred embodiment of the present invention, the esterification reaction temperature in the step (1) is from 30 to 100 ° C; preferably, the esterification reaction temperature is from 40 to 85 ° C.
根据本发明优选的,步骤(1)中所述酯化反应时间为1-8小时。According to a preferred embodiment of the invention, the esterification reaction time in step (1) is from 1 to 8 hours.
根据本发明优选的,步骤(2)中所述碱为无机碱或有机碱;所述无机碱为碳酸钾、碳酸钠、碳酸钙、碳酸氢钾、碳酸氢钠、碳酸氢钙、醋酸钾、醋酸钠、醋酸钙、氢化钠、甲醇钠、乙醇钠、叔丁醇钠、叔丁醇钾或苄醇钠中的一种或两种以上的组合;所述有机碱为三乙胺、三正丁胺、二异丙基乙胺或吡啶中的一种或两种以上的组合。According to the preferred embodiment of the present invention, the base in the step (2) is an inorganic base or an organic base; the inorganic base is potassium carbonate, sodium carbonate, calcium carbonate, potassium hydrogencarbonate, sodium hydrogencarbonate, calcium hydrogencarbonate, potassium acetate, One or a combination of two or more of sodium acetate, calcium acetate, sodium hydride, sodium methoxide, sodium ethoxide, sodium t-butoxide, potassium t-butoxide or sodium benzylate; the organic base is triethylamine, three-positive One or a combination of two or more of butylamine, diisopropylethylamine or pyridine.
根据本发明优选的,步骤(2)中所述碱与L-谷氨酸二酯盐酸盐(III)的摩尔比为1.0-2.0:1。According to a preferred embodiment of the invention, the molar ratio of the base to the L-glutamic acid diester hydrochloride (III) in step (2) is from 1.0 to 2.0:1.
根据本发明优选的,步骤(2)中所述溶剂为1,2-二氯乙烷、1,1,2-三氯乙烷、四氢呋喃、2-甲基四氢呋喃、甲氧基环戊烷、苯、甲苯或二甲苯中的一种或两种以上的组合。According to the preferred embodiment of the present invention, the solvent in the step (2) is 1,2-dichloroethane, 1,1,2-trichloroethane, tetrahydrofuran, 2-methyltetrahydrofuran, methoxycyclopentane, One or a combination of two or more of benzene, toluene or xylene.
根据本发明优选的,步骤(2)中所述溶剂与L-谷氨酸二酯盐酸盐(III)的质量比为4-20:1。According to a preferred embodiment of the invention, the mass ratio of the solvent to the L-glutamic acid diester hydrochloride (III) in the step (2) is from 4 to 20:1.
根据本发明优选的,步骤(2)中所述N-取代基保护试剂为二碳酸二叔丁基酯、氯甲酸苄酯、氯甲酸乙酯、氯甲酸烯丙酯、氯甲酸叔丁基酯或氯甲酸苯酯中的一种。According to the preferred embodiment of the present invention, the N-substituent protecting agent in the step (2) is di-tert-butyl dicarbonate, benzyl chloroformate, ethyl chloroformate, allyl chloroformate, tert-butyl chloroformate. Or one of phenyl chloroformate.
根据本发明优选的,步骤(2)中所述N-取代基保护试剂和L-谷氨酸二酯盐酸盐(III)的摩尔比为1.0-2.0:1。According to a preferred embodiment of the present invention, the molar ratio of the N-substituent protecting agent to the L-glutamic acid diester hydrochloride (III) in the step (2) is from 1.0 to 2.0:1.
根据本发明优选的,步骤(2)中所述N-取代保护反应温度为-20-80℃;优选的,所述N-取代保护反应温度为20-50℃。According to a preferred embodiment of the present invention, the N-substituted protection reaction temperature in the step (2) is from -20 to 80 ° C; preferably, the N-substituted protection reaction temperature is from 20 to 50 ° C.
根据本发明优选的,步骤(2)中所述N-取代保护反应时间为2-10小时。According to a preferred embodiment of the invention, the N-substituent protection reaction time in step (2) is from 2 to 10 hours.
根据本发明优选的,步骤(2)中所述脱醇环合反应温度为60-120℃;优选的,所述脱醇环合反应温度为70-105℃。According to a preferred embodiment of the present invention, the dealcoholization ring-closing reaction temperature in the step (2) is from 60 to 120 ° C; preferably, the dealcoholization ring-closing reaction temperature is from 70 to 105 ° C.
根据本发明优选的,步骤(2)所述脱醇环合反应时间为2-8小时。According to a preferred embodiment of the invention, the dealcoholation ring closure reaction time of step (2) is from 2 to 8 hours.
本发明描述为如下反应路线(反应路线2):The invention is described as the following reaction route (Scheme 2):
本发明的技术特点和有益效果:Technical features and beneficial effects of the present invention:
1、本发明以L-谷氨酸(Ⅱ)为初始原料,在醇和酸性试剂存在下,经酯化反应制备L-谷氨酸二酯盐酸盐(III);然后在碱性条件下和N-取代基保护试剂反应引入N-取代保护基,经加热分子内脱醇环合,“一锅法”得到N-取代-L-焦谷氨酸酯(I)。1. The present invention uses L-glutamic acid (II) as a starting material to prepare L-glutamic acid diester hydrochloride (III) by esterification in the presence of an alcohol and an acidic reagent; The N-substituent protecting reagent is introduced into the N-substituted protecting group, and the in-molecular dealcoholation is carried out by heating, and the "one-pot method" is carried out to obtain N-substituted-L-pyroglutamic acid ester (I).
2、与现有技术相比,本发明不使用溴卞或氯苄,无危害、绿色环保;本发明以L-谷氨酸(Ⅱ)为初始原料,原料价廉易得,反应类型经典,工艺路线短,操作简便,产品成本低;本发明不需要对产物进 行洗涤,废水产生量少,并且所用溶剂等有机原料可以回收再利用,绿色环保,能有效降低成本;且反应收率高,总收率高达93.4%。2. Compared with the prior art, the invention does not use bromine or benzyl chloride, and is harmless and environmentally friendly; the invention uses L-glutamic acid (II) as a starting material, and the raw materials are cheap and easy to obtain, and the reaction type is classic. The invention has the advantages of short process route, simple operation and low product cost; the invention does not need to wash the product, the amount of waste water is small, and the organic raw materials such as the solvent used can be recycled and reused, environmentally friendly, can effectively reduce the cost; and the reaction yield is high, The total yield is as high as 93.4%.
以下结合实施例详细说明了本发明,但本发明不仅局限于此。The invention is described in detail below with reference to the examples, but the invention is not limited thereto.
实施例中的%均为质量百分比,有特别说明的除外。% in the examples are percentages by mass unless otherwise specified.
利用气相或液相色谱仪监控反应过程和产品纯度,利用配有手性柱(ES-OVS,150mm×4.6mm,安捷伦公司)的液相色谱仪检测光学纯度(面积比%),并计算收率和e.e%值。The reaction process and product purity were monitored by gas phase or liquid chromatography, and the optical purity (area ratio %) was measured by a liquid chromatograph equipped with a chiral column (ES-OVS, 150 mm × 4.6 mm, Agilent), and the calculation was performed. Rate and ee% value.
实施例1:L-谷氨酸二苄酯盐酸盐(Ⅲ 1)的制备 Example 1: Preparation of L-glutamic acid dibenzyl ester hydrochloride (III 1 )
向装有搅拌、温度计和回流冷凝管(连接30%氢氧化钠水溶液吸收装置)的500毫升四口烧瓶中加入280克苄醇,14.7克(0.10摩尔)L-谷氨酸,30.0克(0.25摩尔)氯化亚砜,加热,80~85℃反应5小时,冷却至20~25℃,氮气置换体系中的氯化氢气体,置换30分钟后,蒸馏回收过量的氯化亚砜和苄醇,然后向剩余物中加入120克甲基叔丁醚,打浆,过滤,干燥,得到35.9克白色固体L-谷氨酸二苄酯盐酸盐,液相纯度99.8%,收率为98.7%。Add 280 g of benzyl alcohol, 14.7 g (0.10 mol) of L-glutamic acid, 30.0 g (0.25) to a 500 ml four-necked flask equipped with a stirring, thermometer and reflux condenser (connected to a 30% aqueous sodium hydroxide absorption unit). Molyl) thionyl chloride, heated, reacted at 80-85 ° C for 5 hours, cooled to 20 ~ 25 ° C, nitrogen exchange system hydrogen chloride gas, after 30 minutes of replacement, distillation of excess thionyl chloride and benzyl alcohol, and then To the residue was added 120 g of methyl tert-butyl ether, which was beaten, filtered, and dried to give 35.9 g of white solid L-glutamic acid dibenzyl ester hydrochloride. The liquid phase purity was 99.8%, and the yield was 98.7%.
实施例2:L-谷氨酸二苄酯盐酸盐(Ⅲ 1)的制备 Example 2: Preparation of L-glutamic acid dibenzyl ester hydrochloride (III 1 )
向装有搅拌、温度计和回流冷凝管(连接30%氢氧化钠水溶液吸收装置)的500毫升四口烧瓶中加入280克苄醇,14.7克(0.10摩尔)L-谷氨酸,30.0克(0.15摩尔)双光气,加热,70~75℃反应6小时,冷却至20~25℃,氮气置换体系中的氯化氢气体,置换30分钟后。蒸馏回收过量的双光气和苄醇,然后向剩余物中加入120克甲基叔丁醚,打浆,过滤,干燥,得到35.5克白色固体L-谷氨酸二苄酯盐酸盐,液相纯度99.7%,收率为97.6%。Add 280 g of benzyl alcohol, 14.7 g (0.10 mol) of L-glutamic acid, 30.0 g (0.15) to a 500 ml four-necked flask equipped with a stirring, thermometer and reflux condenser (connected to a 30% aqueous sodium hydroxide absorption unit). Mohr) Double phosgene, heated, reacted at 70 to 75 ° C for 6 hours, cooled to 20 to 25 ° C, and replaced with hydrogen chloride gas in a nitrogen system for 30 minutes. Excess diphosgene and benzyl alcohol were distilled off, and then 120 g of methyl tert-butyl ether was added to the residue, beaten, filtered, and dried to obtain 35.5 g of a white solid L-glutamic acid dibenzyl ester hydrochloride. The purity was 99.7%, and the yield was 97.6%.
实施例3:L-谷氨酸二乙酯盐酸盐(Ⅲ 2)的制备 Example 3: Preparation of L-glutamic acid diethyl ester hydrochloride (III 2 )
向装有搅拌、温度计和回流冷凝管(连接30%氢氧化钠水溶液吸收装置)的500毫升四口烧瓶中加入300克乙醇,14.7克(0.10摩尔)L-谷氨酸,25.0克(0.08摩尔)三光气,加热,70~75℃反应5小时,冷却至20~25℃,氮气置换体系中的氯化氢气体,置换30分钟后。蒸馏回收过量的三光气和乙醇,然后向剩余物中加入100克甲基叔丁醚,打浆,过滤,干燥,得到23.5克白色固体L-谷氨酸二乙酯盐酸盐,液相纯度99.7%,收率为98.0%。Add 300 g of ethanol, 14.7 g (0.10 mol) of L-glutamic acid, 25.0 g (0.08 mol) to a 500 ml four-necked flask equipped with a stirring, thermometer and reflux condenser (connected to a 30% aqueous sodium hydroxide absorption unit). The triphosgene is heated, reacted at 70 to 75 ° C for 5 hours, cooled to 20 to 25 ° C, and replaced with hydrogen chloride gas in a nitrogen gas system for 30 minutes. Excess triphosgene and ethanol were distilled off, and then 100 g of methyl tert-butyl ether was added to the residue, beaten, filtered, and dried to obtain 23.5 g of a white solid L-glutamic acid diethyl ester hydrochloride. The liquid phase purity was 99.7. %, the yield was 98.0%.
实施例4:L-谷氨酸二甲酯盐酸盐(Ⅲ 3)的制备 Example 4: Preparation of L-glutamic acid dimethyl ester hydrochloride (III 3 )
向装有搅拌、温度计和回流冷凝管(连接30%氢氧化钠水溶液吸收装置)的500毫升四口烧瓶中加入300克甲醇,14.7克(0.10摩尔)L-谷氨酸,30.0克(0.25摩尔)氯化亚砜,加热,60~63℃反应7小时,冷却至20~25℃,氮气置换体系中的氯化氢气体,置换30分钟后,蒸馏回收过量的氯化亚砜和甲醇,然后向剩余物中加入100克甲基叔丁醚,打浆,过滤,干燥,得到20.8克白色固体L-谷氨酸二甲酯盐酸盐,液相纯度99.5%,收率为98.1%。Add 300 g of methanol, 14.7 g (0.10 mol) of L-glutamic acid, 30.0 g (0.25 mol) to a 500 ml four-necked flask equipped with a stirring, thermometer and reflux condenser (connected to a 30% aqueous sodium hydroxide absorption unit). The thionyl chloride is heated, reacted at 60-63 ° C for 7 hours, cooled to 20-25 ° C, replaced with hydrogen chloride gas in the nitrogen system, and after 30 minutes of replacement, the excess thionyl chloride and methanol are distilled off and then left to the remainder. 100 g of methyl tert-butyl ether was added, beaten, filtered, and dried to obtain 20.8 g of a white solid L-glutamic acid dimethyl ester hydrochloride. The liquid phase purity was 99.5%, and the yield was 98.1%.
实施例5:N-叔丁基氧基羰基-L-焦谷氨酸苄酯(Ⅰ 1)的制备 Example 5: Preparation of N-tert-Butoxycarbonyl-L-pyroglutamic acid benzyl ester (I 1 )
向装有搅拌、温度计和回流冷凝管的500毫升四口烧瓶中加入18.2克(0.05摩尔)实施例1制备的L-谷氨酸二苄酯盐酸盐,150克甲苯,7.8克(0.06摩尔)二异丙基乙胺,12.0克(0.055摩尔)二碳酸二 叔丁基酯,加热,30~35℃反应4小时,90~95℃反应5小时,冷却至20~25℃,过滤,蒸馏滤液回收溶剂,向剩余物中加入50克甲基叔丁醚重结晶,过滤,干燥,得到15.1克白色粉末固体N-叔丁基氧基羰基-L-焦谷氨酸苄酯,液相纯度99.9%,收率为94.6%。To a 500 ml four-necked flask equipped with a stirring, a thermometer and a reflux condenser, 18.2 g (0.05 mol) of L-glutamic acid dibenzyl ester hydrochloride prepared in Example 1, 150 g of toluene, 7.8 g (0.06 mol) was added. Diisopropylethylamine, 12.0 g (0.055 mol) of di-tert-butyl dicarbonate, heated, reacted at 30-35 ° C for 4 hours, reacted at 90-95 ° C for 5 hours, cooled to 20-25 ° C, filtered, distilled The solvent was recovered from the filtrate, and 50 g of methyl tert-butyl ether was added to the residue to recrystallize, filtered, and dried to give 15.1 g of white powder solid N-tert-butyloxycarbonyl-L-pyroglutamic acid benzyl ester. 99.9%, the yield was 94.6%.
所得产品核磁数据如下: 1H-NMR(400MHz,CDCl 3)δ:1.42(9H,s),2.01(1H,m),2.30(1H,m),2.49(1H,m),2.58(1H,m),4.63(1H,t),5.20(2H,m),7.36(5H,m)。 The nuclear magnetic data of the obtained product are as follows: 1 H-NMR (400 MHz, CDCl 3 ) δ: 1.42 (9H, s), 2.01 (1H, m), 2.30 (1H, m), 2.49 (1H, m), 2.58 (1H, m), 4.63 (1H, t), 5.20 (2H, m), 7.36 (5H, m).
实施例6:N-叔丁基氧基羰基-L-焦谷氨酸苄酯(Ⅰ 1)的制备 Example 6: Preparation of N-tert-Butoxycarbonyl-L-pyroglutamic acid benzyl ester (I 1 )
向装有搅拌、温度计和回流冷凝管的500毫升四口烧瓶中加入18.2克(0.05摩尔)实施例2制备的L-谷氨酸二苄酯盐酸盐,150克1,1,2-三氯乙烷,7.8克(0.06摩尔)二异丙基乙胺,8.2克(0.06摩尔)氯甲酸叔丁基酯,25~30℃反应5小时,80~85℃反应5小时,冷却至20~25℃,过滤,蒸馏滤液回收溶剂,向剩余物中加入50克甲基叔丁醚重结晶,过滤,干燥,得到14.7克白色粉末固体N-叔丁基氧基羰基-L-焦谷氨酸苄酯,液相纯度99.8%,收率为92.0%。To a 500 ml four-necked flask equipped with a stirring, a thermometer and a reflux condenser, 18.2 g (0.05 mol) of L-glutamic acid dibenzyl ester hydrochloride prepared in Example 2, 150 g of 1,1,2-three was added. Ethyl chloride, 7.8 g (0.06 mol) of diisopropylethylamine, 8.2 g (0.06 mol) of t-butyl chloroformate, reacted at 25-30 ° C for 5 hours, reacted at 80-85 ° C for 5 hours, cooled to 20 ° The solvent was distilled off at 25 ° C, and the filtrate was evaporated. The residue was crystallized from 50 g of methyl tert-butyl ether, and filtered, and dried to give 14.7 g of white powder solid N-tert-butyloxycarbonyl-L-pyroglutamic acid Benzyl ester, liquid phase purity 99.8%, yield 92.0%.
实施例7:N-叔丁基氧基羰基-L-焦谷氨酸乙酯(Ⅰ 2)的制备 Example 7: Preparation of N-tert-Butoxycarbonyl-L-pyroglutamic acid ethyl ester (I 2 )
向装有搅拌、温度计和回流冷凝管的500毫升四口烧瓶中加入12.0克(0.05摩尔)实施例3制备的L-谷氨酸二乙酯盐酸盐,120克2-甲基四氢呋喃,8.5克(0.06摩尔)碳酸钾,8.2克(0.06摩尔)氯甲酸叔丁基酯,25~30℃反应5小时,75~80℃反应7小时,冷却至20~25℃,过滤,蒸馏滤液回收溶剂,向剩余物中加入40克甲基叔丁醚重结晶,过滤,干燥,得到11.5克白色粉末固体N-叔丁基氧基羰基-L-焦谷氨酸乙酯,液相纯度99.5%,收率为89.3%。To a 500 ml four-necked flask equipped with a stirring, a thermometer and a reflux condenser, 12.0 g (0.05 mol) of L-glutamic acid diethyl ester hydrochloride prepared in Example 3, 120 g of 2-methyltetrahydrofuran, 8.5 was added. Grams (0.06 mol) potassium carbonate, 8.2 g (0.06 mol) t-butyl chloroformate, react at 25-30 ° C for 5 hours, 75-80 ° C for 7 hours, cool to 20-25 ° C, filter, distill the filtrate to recover solvent To the residue was added 40 g of methyl tert-butyl ether to recrystallize, filtered and dried to give 11.5 g of white powdery solid N-tert-butyloxycarbonyl-L-pyroglutamic acid ethyl ester. The yield was 89.3%.
所得产品核磁数据如下: 1H-NMR(400MHz,CDCl 3)δ:1.21(3H,t),1.46(9H,s),2.02(1H,m),2.31(1H,m),2.48(1H,m),2.59(1H,m),4.16(2H,q),4.61(1H,m)。 The nuclear magnetic data of the obtained product are as follows: 1 H-NMR (400 MHz, CDCl 3 ) δ: 1.21 (3H, t), 1.46 (9H, s), 2.02 (1H, m), 2.31 (1H, m), 2.48 (1H, m), 2.59 (1H, m), 4.16 (2H, q), 4.61 (1H, m).
实施例8:N-苄基氧基羰基-L-焦谷氨酸苄酯(Ⅰ 3)的制备 Example 8: Preparation of N-benzyloxycarbonyl-L-pyroglutamic acid benzyl ester (I 3 )
向装有搅拌、温度计和回流冷凝管的500毫升四口烧瓶中加入18.2克(0.05摩尔)实施例1制备的L-谷氨酸二苄酯盐酸盐,150克1,1,2-三氯乙烷,6.1克(0.06摩尔)三乙胺,10.5克(0.06摩尔)氯甲酸苄酯,35~40℃反应4小时,100~105℃反应3小时,冷却至20~25℃,过滤,蒸馏滤液回收溶剂,向剩余物中加入50克甲基叔丁醚重结晶,过滤,干燥,得到16.2克白色粉末固体N-苄基氧基羰基-L-焦谷氨酸苄酯,液相纯度99.3%,收率为91.7%。To a 500 ml four-necked flask equipped with a stirring, a thermometer and a reflux condenser, 18.2 g (0.05 mol) of L-glutamic acid dibenzyl ester hydrochloride prepared in Example 1, 150 g of 1,1,2-three was added. Ethyl chloride, 6.1 g (0.06 mol) of triethylamine, 10.5 g (0.06 mol) of benzyl chloroformate, reacted at 35 to 40 ° C for 4 hours, reacted at 100 to 105 ° C for 3 hours, cooled to 20 to 25 ° C, and filtered. The solvent was distilled off, and 50 g of methyl tert-butyl ether was added to the residue to recrystallize, filtered, and dried to give 16.2 g of white powder solid N-benzyloxycarbonyl-L-pyroglutamic acid benzyl ester. 99.3%, the yield was 91.7%.
所得产品核磁数据如下: 1H-NMR(400MHz,CDCl 3)δ:2.06(1H,m),2.34(m,1H),2.50(m,1H),2.61(1H,m),4.72(1H,m),5.12(2H,s),5.21(s,2H),7.40-7.20(m,10H)。 The nuclear magnetic data of the obtained product are as follows: 1 H-NMR (400 MHz, CDCl 3 ) δ: 2.06 (1H, m), 2.34 (m, 1H), 2.50 (m, 1H), 2.61 (1H, m), 4.72 (1H, m), 5.12 (2H, s), 5.21 (s, 2H), 7.40-7.20 (m, 10H).
对比例1:N-叔丁基氧基羰基-L-焦谷氨酸苄酯(Ⅰ 1)的制备 Comparative Example 1: Preparation of N-tert-Butoxycarbonyl-L-pyroglutamic acid benzyl ester (I 1 )
向装有搅拌、温度计和回流冷凝管的500毫升四口烧瓶中加入11.0克(0.03摩尔)实施例1制备的L-谷氨酸二苄酯盐酸盐,90克甲苯,4.7克(0.036摩尔)二异丙基乙胺,7.2克(0.033摩尔)二碳酸二叔丁基酯,加热,30~35℃反应4小时,50~55℃反应8小时,冷却至20~25℃,过滤,蒸馏滤液回收溶剂,向剩余物中加入30克甲基叔丁醚重结晶,过滤,干燥,得到2.2克白色粉末固体N-叔丁基氧基羰基-L-焦谷氨酸苄酯,液相纯度99.1%,收率为23.0%。To a 500 ml four-necked flask equipped with a stirring, a thermometer and a reflux condenser, 11.0 g (0.03 mol) of L-glutamic acid dibenzyl ester hydrochloride prepared in Example 1, 90 g of toluene, 4.7 g (0.036 mol) was added. Diisopropylethylamine, 7.2 g (0.033 mol) of di-tert-butyl dicarbonate, heated, reacted at 30-35 ° C for 4 hours, reacted at 50-55 ° C for 8 hours, cooled to 20-25 ° C, filtered, distilled The solvent was recovered from the filtrate, and 30 g of methyl tert-butyl ether was added to the residue to recrystallize, filtered, and dried to give 2.2 g of white powdery solid N-tert-butyloxycarbonyl-L-pyroglutamic acid benzyl ester. 99.1%, the yield was 23.0%.
由本对比例可知,脱醇环合反应温度对最终产物的收率影响较大,脱醇环合温度过低,会造成最终 产物收率的急剧下降。It can be seen from the present comparative examples that the temperature of the dealcoholization ring reaction has a great influence on the yield of the final product, and the temperature of the dealcoholization ring is too low, which causes a sharp drop in the yield of the final product.
Claims (10)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710904167.4 | 2017-09-29 | ||
| CN201710904167.4A CN107602436A (en) | 2017-09-29 | 2017-09-29 | A kind of environment-friendly preparation method thereof of N substitutions L pyroglutamic acid esters |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2019062027A1 true WO2019062027A1 (en) | 2019-04-04 |
Family
ID=61059221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN2018/078071 Ceased WO2019062027A1 (en) | 2017-09-29 | 2018-03-06 | Green preparation method for n-substituted-l-pyroglutamic acid ester |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN107602436A (en) |
| WO (1) | WO2019062027A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107602436A (en) * | 2017-09-29 | 2018-01-19 | 新发药业有限公司 | A kind of environment-friendly preparation method thereof of N substitutions L pyroglutamic acid esters |
| CN113321606A (en) * | 2021-06-22 | 2021-08-31 | 吉尔生化(上海)有限公司 | Preparation method of (S) -1- (benzyloxycarbonyl) -5-oxopyrrolidine-2-formic acid |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102127063A (en) * | 2011-01-06 | 2011-07-20 | 深圳市普迈达科技有限公司 | New synthesis technology of anti-cancer drug Raltitrexed |
| CN102827058A (en) * | 2012-09-18 | 2012-12-19 | 江苏德峰药业有限公司 | Production method of N-t-butoxycarbonyl-L-pyroglutamate |
| CN103998424A (en) * | 2011-12-15 | 2014-08-20 | 陶氏环球技术有限责任公司 | Process for preparing alkyl pyroglutamic acids |
| CN107602436A (en) * | 2017-09-29 | 2018-01-19 | 新发药业有限公司 | A kind of environment-friendly preparation method thereof of N substitutions L pyroglutamic acid esters |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112015018092A2 (en) * | 2013-01-29 | 2017-07-18 | Naurex Inc | spiro-lactam nmda receptor modulators and uses thereof |
| CN104628622A (en) * | 2015-01-29 | 2015-05-20 | 上海应用技术学院 | Preparation method of saxagliptin intermediate |
| CN105732454A (en) * | 2016-02-22 | 2016-07-06 | 济南诚汇双达化工有限公司 | Production technology of L-pyroglutamic acid benzyl ester |
-
2017
- 2017-09-29 CN CN201710904167.4A patent/CN107602436A/en active Pending
-
2018
- 2018-03-06 WO PCT/CN2018/078071 patent/WO2019062027A1/en not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102127063A (en) * | 2011-01-06 | 2011-07-20 | 深圳市普迈达科技有限公司 | New synthesis technology of anti-cancer drug Raltitrexed |
| CN103998424A (en) * | 2011-12-15 | 2014-08-20 | 陶氏环球技术有限责任公司 | Process for preparing alkyl pyroglutamic acids |
| CN102827058A (en) * | 2012-09-18 | 2012-12-19 | 江苏德峰药业有限公司 | Production method of N-t-butoxycarbonyl-L-pyroglutamate |
| CN107602436A (en) * | 2017-09-29 | 2018-01-19 | 新发药业有限公司 | A kind of environment-friendly preparation method thereof of N substitutions L pyroglutamic acid esters |
Non-Patent Citations (2)
| Title |
|---|
| CAMILLE G. WERMUTH ET AL.: "2S, 4S)-2-Amino-4-(4, 4-diphenylbut-1-yl)-pentane-1, 5-dioic Acid: A Potent and Selective Antagonist for Metabotropic Glutamate Receptors Negatively Linked to Adenylate Cyclase", J. MED. CHEM., vol. 39, no. 4, 16 February 1996 (1996-02-16), pages 814 - 816, XP055588901 * |
| PAUL LE MAUX ET AL.: "Chemical reactivity of 6-diazo-5-oxo-L-norleucine (DON) catalyzed by metalloporphyrins (Fe, Ru", TETRAHEDRON, vol. 66, no. 25, 24 April 2010 (2010-04-24), pages 4462 - 4468, XP055362317, ISSN: 0040-4020, DOI: doi:10.1016/j.tet.2010.04.080 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN107602436A (en) | 2018-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4170753B2 (en) | Method for producing oxazolidinone compound | |
| TWI413638B (en) | Novel method | |
| KR900003495B1 (en) | Antibacterial carboxilic acids | |
| RU2730006C1 (en) | Method of producing 5r-[(benzyloxy)amino]piperidine-2s-carboxylic acid or derivative thereof | |
| TWI438188B (en) | Production method of intermediate compound for synthesizing medicament | |
| JP2019528254A (en) | Improved 5R-benzyloxyaminopiperidine-2S-formic acid ester and process for preparing the oxalate salt thereof | |
| EP2958894A1 (en) | Process for the preparation of enantiomerically enriched 3-aminopiperidine | |
| WO2019062027A1 (en) | Green preparation method for n-substituted-l-pyroglutamic acid ester | |
| JP5548129B2 (en) | Asymmetric organic catalyst | |
| JPWO2012026529A1 (en) | Novel production method of isoquinoline derivative or salt thereof | |
| NO317984B1 (en) | Process for the preparation of enantiomerically pure N-methyl-N - [(1S or 1R) -1-phenyl-2 - ((3S or 3R) -3-hydroxypyrrolidin-1-yl) ethyl] -2,2-diphenylacetamide, using of the (1S, 3S) enantiomer to prepare a pharmaceutical composition | |
| WO2023226900A1 (en) | 2-(piperazine-2-yl) acetonitrile derivative, preparation method for, and use thereof | |
| JP5191385B2 (en) | Succinic acid diester derivative, process for its preparation and use of said derivative in pharmaceutical manufacture | |
| CN112409286B (en) | Synthesis method of N-substituted phenyl-5-hydroxymethyl-2-oxazolidinone | |
| JP5709101B2 (en) | Method for producing hydroxyproline derivative | |
| WO2014155264A1 (en) | Process for the preparation of lacosamide using novel intermediates | |
| US6531594B2 (en) | Process for producing 1H-3-aminopyrrolidine and derivatives thereof | |
| RU2742765C1 (en) | Method for preparing intermediate compound for synthesis of medicinal agent | |
| CN104788431A (en) | Synthetic method for chiral marine natural product with high optical activity | |
| JP4300821B2 (en) | Amino acid compounds | |
| JP2002316977A (en) | Method for producing optically active 1H-3-aminopyrrolidine compound | |
| KR20010053805A (en) | A process for producing amino acid or aminoalcohol with t-Butoxycarbonyl group | |
| WO2019066578A1 (en) | Process for preparing intermediate compound for pharmaceutical synthesis | |
| EP0456310A2 (en) | Enantioselective synthesis of 3-substituted 1-azabicyclo [2.2.1]heptanes | |
| KR20010053804A (en) | A process for producing amine with t-Butoxycarbonyl group |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18862583 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 18862583 Country of ref document: EP Kind code of ref document: A1 |